NEW YORK (GenomeWeb) – Waters disclosed in a filing with the US Securities and Exchange Commission on Friday that it has sold $250 million in senior notes to institutional accredited investors.

The mass spectrometry and chromatography equipment manufacturer didn't name the purchasers but said that it sold three series of senior notes in the private placement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.